Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

    This grant funds research to develop and optimize new devices for brain and addiction disorders, supporting their progress toward readiness for initial human trials.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    This grant has transitioned from forecasted to posted and is now accepting applications.

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027

    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

    This grant will fund early-stage clinical studies of new devices for recording or stimulating the human brain to treat neurological disorders and advance brain science, encouraging partnerships between researchers and device manufacturers.

    HHS-NIH11Forecasted Jan 28, 2027$10,000,000Forecasted

    Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

    This grant will fund partnerships to expand the use and integration of BRAIN Initiative neurotechnologies at institutions with limited NIH research funding, supporting two-way knowledge transfer and training.

    HHS-NIH11Forecasted Jun 17, 2027Forecasted

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026· 15d$150,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted